Vnitr Lek 2017, 63(7-8):527-530 | DOI: 10.36290/vnl.2017.107
Infectious complications related to liver transplants
- Centrum kardiovaskulární a transplantační chirurgie, Brno
Infection is a feared complication in the process of transplantation. The study discusses sources of infection, screening of infection and risk factors for infection, time occurrence of individual infections during the peritransplantation and posttransplantation course. It describes the most frequent forms of bacterial, viral and mycotic infections. It specifies efficient prophylactic measures that considerably reduce the risk of infection following liver transplantation.
Keywords: bacterial infection; cytomegalovirus (CMV); EB virus (EBV); hepatitis B (HBV); hepatitis C (HCV); liver transplantation; mycotic infection prophylaxis; risk factors; viral infection
Received: April 13, 2017; Accepted: June 20, 2017; Published: July 1, 2017 Show citation
References
- Sun HY, Cacciarelli TV, Singh N. Impact of pretransplant infections on clinical outcomes of liver transplant recipients. Liver Transplantation 2010; 16(2): 222-228. Dostupné z DOI: <http://dx.doi.org/10.1002/lt.21982>.
Go to original source...
Go to PubMed...
- Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338(4): 1741-1751.
Go to original source...
Go to PubMed...
- Romero FA, Razonable RR. Infections in liver transplant recipients. World J Hepatol 2011; 3(4): 83-92. Dostupné z DOI: <http://dx.doi.org/10.4254/wjh.v3.i4.83>.
Go to original source...
Go to PubMed...
- Brayman KL, Stephanian E, Matas AJ et al. Analysis of infectious complications occurring after solid-organ transplantation. Arch Surg 1992; 127(1): 38-48.
Go to original source...
Go to PubMed...
- Singh N, Wagener NM, Gayowski T et al. Trends in invasive fungal infections in liver transplant recipients: Correlation with evolution in transplant practices. Transplantation 2002; 73(1): 63-67.
Go to original source...
Go to PubMed...
- Eschenauer GA, Lam SW, Carver PL. Antifungal prophylaxis in liver transplant recipients. Liver Transplant 2009; 15(8): 842-858. Dostupné z DOI: <http://dx.doi.org/10.1002/lt.21826>. Erratum in Liver Transpl 2010; 16(6): 797-805.
Go to original source...
Go to PubMed...
- Fortun J, Martin-Davila P, Moreno S et al. Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transpl 2002; 8(11): 1065-1070.
Go to original source...
Go to PubMed...
- Liang TJ, Ghany MG. Current and future therapies for hepatitis C virus infection. N Engl J Med 2013; 368(20): 1907-1917. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMra1213651>.
Go to original source...
Go to PubMed...
- Kalil AC, Mindru C, Botha JF et al. Risk of cytomegalovirus disease in high-risk liver transplant recipients on valganciclovir Prophylaxis: A systematic review and meta-analysis. Liver Transpl 2012; 18(12): 1440-1447. Dostupné z DOI: <http://dx.doi.org/10.1002/lt.23530>.
Go to original source...
Go to PubMed...
- Torre-Cisneros H, de la Mata M, Lopez-Cillero P et al. Effectiveness of daily low-dose cotrimoxazole prophylaxis for Pneumocystis carinii pneumonia in liver transplantation - an open clinical trial. Transplantation 1996; 62(10): 1519-1521.
Go to original source...
Go to PubMed...
- Holt D, Winston J, Busuttil R et al. Infections after Liver Transplantation. In: Ronald W. Busuttil RW, Klintmalm GB (eds).Transplantation of The Liver. 3rd ed. 2015: 1006-1030. ISBN: 978-1-4557-0268-8. Dostupné z DOI: <https://doi.org/10.1016/B978-1-4557-0268-8.12001-9>.
Go to original source...